Scope of Responsibilities
- Application of analytical and biophysical characterization techniques such as flow and nanoflow cytometry, ELISA, qPCR/ddPCR and protein analytics.
- Analytical assay development for cell and gene therapy.
- Assay qualification and tech transfer activities to QC.
- Performance of general laboratory tasks, including maintenance and troubleshooting of equipment
- Maintain accurate and reliable records including database management, lab notebooks, and all other pertinent documentation.
- Writing and/or contributing to protocols, test methods and reports.
- Comply with all environmental health and safety standards.
- This is a hands-on lab-based position requiring a flexible schedule based on experimental work
Minimum Qualifications
- Ph. D. in chemical engineering, biology, biotechnology, or related discipline or Master’s degree with 5+ years or Bachelor’s degree with 8+ years of relevant experience.
- Strong team worker who is also independently motivated, detail oriented and possesses good problem-solving capabilities.
- Demonstrated ability to work both independently as well as part of interdisciplinary team.
- Excellent organizational skills
- Strong verbal and written skills; able to handle confidential information and material appropriately
Preferred Qualifications
- PhD with a minimum of two, MS with a minimum of eight years of appropriate work experience in cell and gene therapy or related discipline are preferred.
- Demonstrate experience using protein and genome-based techniques (e.g. nanoparticle characterization, gel electrophoresis, western blotting, capillary electrophoresis, flow/nanoflow cytometry, ELISA and qualitative/quantitative PCR (qPCR, dPCR, ddPCR)).
- Experience/knowledge of extracellular vesicles to physically, chemically and biologically characterize.
- Experience/knowledge to support, in-process characterization, method transfer and release testing of drug substance and drug products.
- Experience in multiple aspects of aseptic mammalian cell culture, cell enumeration and phenotypic characterization.
Top Skills
What We Do
Landmark Bio is a collective endeavor launched by leaders from academia, the life sciences industry, and world-renowned research hospitals to accelerate development and industrialization of next-generation genomic medicine. Inspired by recent advancements in cell and gene therapy, Landmark Bio was established to remove barriers in drug development, create accessible capability, expertise, and solutions, and offer a collaboration platform to advance manufacturing technologies for the new generation of medicines to come. Founding partners include Harvard University, Massachusetts Institute of Technology (MIT), Cytiva, FUJIFILM Diosynth Biotechnologies (FDB), and Alexandria Real Estate Equities, Inc. Other collaborating institutions include Beth Israel Deaconess Medical Center, Boston Children’s Hospital, Mass General Brigham, and the Dana-Farber Cancer Institute. For more information please contact [email protected]
Why Work With Us
Landmark Bio was conceived to accelerate life sciences innovation. Our cross-sector network, expert staff and consultants, state-of-the-art facility, and broad definition of how a true partner can expedite translational research make us unique. Our mission Is to translate groundbreaking research into life-changing therapies.
Gallery
